HCPCS Level II · retired code
Q5131 — Injection, adalimumab-aacf (idacio), biosimilar, 20 mg
Q5131 was retired on Dec 31, 2024
CMS ended Q5131 after Dec 31, 2024. Don’t report it for later dates of service. Current codes for the same drug:
- J0139Injection, adalimumab, 1 mg
- Q5140Injection, adalimumab-fkjp, biosimilar, 1 mg
- Q5141Injection, adalimumab-aaty, biosimilar, 1 mg
- Q5142Injection, adalimumab-ryvk biosimilar, 1 mg
- Q5143Injection, adalimumab-adbm, biosimilar, 1 mg
- Q5144Injection, adalimumab-aacf (idacio), biosimilar, 1 mg
- Q5145Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg
Code
CMS HCPCS fileHCPCS codeQ5131
Billing unit20 mg
- Descriptor
- Injection, adalimumab-aacf (idacio), biosimilar, 20 mg
- Short descriptor
- Inj, idacio, 20 mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2025
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Find the NDC
Med-Code hasn’t mapped Q5131 to specific products yet. Search the FDA NDC Directory for the drug named in the descriptor, and check the route and strength match the code.
Q5131: common questions
- Is Q5131 a CPT code?
- No. Q5131 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What is one billing unit of Q5131?
- One unit of Q5131 is 20 mg, as stated in the code's descriptor. Units to report = dose given ÷ 20 mg. J-code billing units.